Macrobid Dosage for Uncomplicated UTI
For uncomplicated urinary tract infections in women, prescribe nitrofurantoin monohydrate/macrocrystals (Macrobid) 100 mg twice daily for 5 days. 1
Standard Dosing Regimen
- Nitrofurantoin monohydrate/macrocrystals: 100 mg orally twice daily for 5-7 days is the IDSA-recommended first-line regimen for uncomplicated cystitis in women 2, 1
- The 5-day duration is optimal and specifically endorsed by both the Infectious Diseases Society of America and European Society for Microbiology and Infectious Diseases 1
- This regimen achieves clinical cure rates of 88-93% and bacterial cure rates of 81-92% 1
Alternative Dosing for Specific Situations
For VRE (vancomycin-resistant enterococci) UTIs:
- Use 100 mg orally four times daily (every 6 hours) 2, 1
- This higher frequency dosing is necessary for resistant organisms 2
Macrocrystal formulation (if monohydrate/macrocrystals unavailable):
- 50-100 mg orally four times daily for 5 days 1
Duration Considerations
- Do not extend treatment beyond 7 days unless symptoms persist, as shorter courses minimize adverse effects while maintaining efficacy 1
- The 5-day regimen has been proven equivalent to trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days in both clinical and microbiological outcomes 1
- Three-day regimens are less well-studied for nitrofurantoin compared to other agents and are not standard 2
Critical Contraindications
Avoid nitrofurantoin if:
- Early pyelonephritis is suspected - nitrofurantoin does not achieve adequate tissue concentrations in the renal parenchyma 1
- Severe renal impairment is present (though mild-moderate reduction in GFR does not preclude use) 3
Common Pitfalls to Avoid
- Do not use single-dose nitrofurantoin - this is statistically less effective than 3-7 day courses 4
- Do not prescribe for complicated UTIs or pyelonephritis - tissue penetration is inadequate for upper tract infections 1
- Do not avoid in mild-moderate renal dysfunction - studies show efficacy is maintained even with estimated GFR around 38 mL/min per 1.73 m² 3
Expected Side Effects
- Nausea and headache are the most common adverse effects 1
- Overall adverse event rates range from 5.6-34% across studies 1